Literature DB >> 12515723

Cell death induced by granzyme C.

Hillary Johnson1, Luca Scorrano, Stanley J Korsmeyer, Timothy J Ley.   

Abstract

Although the functions of granzymes A and B have been defined, the functions of the other highly expressed granzymes (Gzms) of murine cytotoxic lymphocytes (C, D, and F) have not yet been evaluated. In this report, we describe the ability of murine GzmC (which is most closely related to human granzyme H) to cause cell death. The induction of death requires its protease activity and is characterized by the rapid externalization of phosphatidylserine, nuclear condensation and collapse, and single-stranded DNA nicking. The kinetics of these events are similar to those caused by granzyme B, and its potency (defined on a molar basis) is also equivalent. The induction of death did not involve the activation of caspases, the cleavage of BID, or the activation of the CAD nuclease. However, granzyme C did cause rapid mitochondrial swelling and depolarization in intact cells or in isolated mitochondria, and this mitochondrial damage was not prevented by cyclosporin A pretreatment. These results suggest that granzyme C rapidly induces target cell death by attacking nuclear and mitochondrial targets and that these targets are distinct from those used by granzyme B to cause classical apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515723     DOI: 10.1182/blood-2002-08-2485

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

Review 1.  A quarter century of granzymes.

Authors:  C L Ewen; K P Kane; R C Bleackley
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

Review 2.  Diversity and function of group 1 innate lymphoid cells.

Authors:  Victor S Cortez; Marco Colonna
Journal:  Immunol Lett       Date:  2016-07-06       Impact factor: 3.685

3.  Granzymes and caspase 3 play important roles in control of gammaherpesvirus latency.

Authors:  Joy Loh; Dori A Thomas; Paula A Revell; Timothy J Ley; Herbert W Virgin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 4.  Use of protease proteomics to discover granzyme B substrates.

Authors:  Andrew J Bredemeyer; R Reid Townsend; Timothy J Ley
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 5.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

6.  Structure of granzyme C reveals an unusual mechanism of protease autoinhibition.

Authors:  Dion Kaiserman; Ashley M Buckle; Petra Van Damme; James A Irving; Ruby H P Law; Antony Y Matthews; Tanya Bashtannyk-Puhalovich; Chris Langendorf; Philip Thompson; Joël Vandekerckhove; Kris Gevaert; James C Whisstock; Phillip I Bird
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-19       Impact factor: 11.205

7.  SerpinB1 controls encephalitogenic T helper cells in neuroinflammation.

Authors:  Lifei Hou; Deepak A Rao; Koichi Yuki; Jessica Cooley; Lauren A Henderson; A Helena Jonsson; Dion Kaiserman; Mark P Gorman; Peter A Nigrovic; Phillip I Bird; Burkhard Becher; Eileen Remold-O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

8.  Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death.

Authors:  Denis Martinvalet; Derek M Dykxhoorn; Roger Ferrini; Judy Lieberman
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

9.  Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses.

Authors:  Yonas Getachew; Heather Stout-Delgado; Bonnie C Miller; Dwain L Thiele
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  Differential expression of granzyme B and C in murine cytotoxic lymphocytes.

Authors:  Sheng F Cai; Todd A Fehniger; Xuefang Cao; Joshua C Mayer; Joel D Brune; Anthony R French; Timothy J Ley
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.